Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Leukemia, Myelomonocytic, Chronic × Interleukin-2 × 30 days × Clear all

Sponsor

Conditions

Recurrence 2 Ovarian Neoplasms 2 Melanoma 2 Leukemia, Myeloid, Acute 2 Leukemia 2 Vulvar Neoplasms 1 Vulvar Diseases 1 Uterine Cervical Dysplasia 1 Stomach Neoplasms 1 Sarcoma 1 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 1 Pleural Effusion, Malignant 1 Papillomavirus Infections 1 Pancreatic Neoplasms 1 Neoplasm Metastasis 1 Mesothelioma, Malignant 1 Meningeal Neoplasms 1 Lymphoma, B-Cell 1 Lymphoma 1 Leukemia, Myeloid 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Gastrointestinal Neoplasms 1 Gallbladder Neoplasms 1 Esophageal Neoplasms 1 Colonic Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma in Situ 1 Adenocarcinoma of Lung 1

Interventions

Azacitidine 7 venetoclax 6 Specimen Handling 6 Biopsy 6 Injections 5 Stem Cell Transplantation 4 Decitabine 4 Cytarabine 4 fludarabine 3 Cyclophosphamide 3 olutasidenib 2 fludarabine phosphate 2 decitabine and cedazuridine drug combination 2 cedazuridine 2 X-Rays 2 Whole-Body Irradiation 2 Vorinostat 2 Mycophenolic Acid 2 Magnetic Resonance Spectroscopy 2 Lenalidomide 2 Hematopoietic Stem Cell Transplantation 2 Granulocyte Colony-Stimulating Factor 2 Filgrastim 2 Cyclosporins 2 Cyclosporine 2 Cladribine 2 Carboplatin 2 CPX-351 2 veliparib 1 treosulfan 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡